Dr. Shah conducts translational research using a porcine model of ischemic cardiac arrest and leads additional studies focused on therapies for the treatment of cardiac arrest. He is also involved in multiple clinical trials evaluating devices and therapies for the treatment of coronary and peripheral arterial disease. In addition, Dr. Shah conducts investigator-initiated studies exploring novel therapies for structural heart disease.
UCLA/Harbor
Torrance, CA
- Interventional Cardiology
2006
UCLA/Olive View
Los Angeles, CA
- Cardiovascular Diseases
2005
Northwestern University
Chicago, IL
- Internal Medicine
2002
University of Illinois
Chicago, IL
MD - Medicine
1999
Stanford University
Stanford CA
BA - International Relations
1994
The use of PK Papyrus covered coronary stent for carotid reconstruction: an initial institutional experience.
The use of PK Papyrus covered coronary stent for carotid reconstruction: an initial institutional experience. J Neurointerv Surg. 2024 Nov 22; 16(12):1244-1249.
PMID: 38171608
Simultaneous Acute Myocardial Infarction, Aortic Dissection, Pulmonary Embolism, and Pneumothorax: A Diagnostic and Therapeutic Conundrum.
Simultaneous Acute Myocardial Infarction, Aortic Dissection, Pulmonary Embolism, and Pneumothorax: A Diagnostic and Therapeutic Conundrum. JACC Case Rep. 2024 Nov 06; 29(21):102610.
PMID: 39619024
Use of Onyx Frontier™ for intracranial stenting in stroke patients: A multicenter retrospective study.
Use of Onyx Frontier™ for intracranial stenting in stroke patients: A multicenter retrospective study. Interv Neuroradiol. 2024 Oct 21; 15910199241286922.
PMID: 39429004
Impact of extracorporeal cardiopulmonary resuscitation on neurological prognosis and survival in adult patients after cardiac arrest: An individual pooled patient data meta-analysis.
Impact of extracorporeal cardiopulmonary resuscitation on neurological prognosis and survival in adult patients after cardiac arrest: An individual pooled patient data meta-analysis. Resuscitation. 2024 09; 202:110357.
PMID: 39142468
Prevalence of Coronary Microvascular Dysfunction and Epicardial Spasm in Patients With Angina and Myocardial Bridge.
Prevalence of Coronary Microvascular Dysfunction and Epicardial Spasm in Patients With Angina and Myocardial Bridge. J Soc Cardiovasc Angiogr Interv. 2024 Sep; 3(9):102196.
PMID: 39575216
Feasibility of Amulet occluder implantation after failed left atrial appendage occlusion attempt: Insights from the EMERGE LAA postapproval study.
Feasibility of Amulet occluder implantation after failed left atrial appendage occlusion attempt: Insights from the EMERGE LAA postapproval study. Heart Rhythm. 2024 Nov; 21(11):2126-2135.
PMID: 38768843
Angiographic Coronary Slow Flow Is Not a Valid Surrogate for Invasively Diagnosed Coronary Microvascular Dysfunction.
Angiographic Coronary Slow Flow Is Not a Valid Surrogate for Invasively Diagnosed Coronary Microvascular Dysfunction. JACC Cardiovasc Interv. 2024 Apr 08; 17(7):920-929.
PMID: 38599696
Cardiogenic Shock Intravascular Cooling Trial (CHILL-SHOCK).
Cardiogenic Shock Intravascular Cooling Trial (CHILL-SHOCK). J Card Fail. 2024 Jul; 30(7):952-957.
PMID: 38458486
Amulet Occluder Implantation in Patients With Failed Prior Left Atrial Appendage Occlusion: EMERGE LAA Insights.
Amulet Occluder Implantation in Patients With Failed Prior Left Atrial Appendage Occlusion: EMERGE LAA Insights. JACC Cardiovasc Interv. 2024 Feb 12; 17(3):457-459.
PMID: 38355277
First Experience With Amulet in the United States: Early Insights From EMERGE LAA Postapproval Study.
First Experience With Amulet in the United States: Early Insights From EMERGE LAA Postapproval Study. JACC Cardiovasc Interv. 2024 Jan 19.
PMID: 38310499